Our approach of integrated quantitative risk analysis in day-to-day activities and performance management of the company guides our corporate decision-making. Our priority continued to be to safeguard our supply chains, customers and communities we operate within, while we ensured uninterrupted operations and sufficient liquidity within the company.
The company may face a risk of inadequate gross margins on the products manufactured and businesses / subsidiaries with low margins may lead to lower EBITDA and PAT.
In the product development cycle, the transition from the R&D phase to the commercialisation phase may get delayed and the timeline for successfully launching and monetising the technology may further be extended.
There is a risk of potential increase in expenses related to sourcing materials, goods or services, coupled with a high reliance on a limited number of suppliers. This may limit the negotiation power of the Company and further make it vulnerable to price fluctuations and supply disruption.
The company has subsidiaries in numerous geographies across North America, EMEA and Asia Pacific and is exposed to risks on account of external factors originating from geopolitical events which may adversely affect the Company’s international operations.